All Instruments
NovaSeq 6000 Sequencing System is by far our most powerful instrument, designed to adapt to your needs.
All Kits & Reagents
Enabling comprehensive genomic profiling from FFPE samples.
All Selection & Planning Tools
A high-performing, fast, and integrated workflow for sensitive applications such as human whole-genome sequencing
All Software & Informatics Products
DRAGEN v3.9 release now available with multi-cloud support, accuracy improvements and more
All Services
Fast, high-quality, sample-to-data services such as RNA and whole-genome sequencing
All Popular Products
Find popular product groupings for your workflow
All Areas
Our leaders are pioneers of genetic research and clinical applications. They are deeply committed to scientific accessibility, data, and community.
All Techniques
All Technologies
All Training
All Informatics Education
More About Us
Next-generation sequencing is helping Native nations with sovereignty and genetic research
More Career Info
All Investor Information
More Business Solutions
All Legal Information
New page replaces MyIllumina Technical Updates email
All Support Tools
All Product Support Services
Maximize identification of molecularly matched therapies with one biopsy, one test, one report
All Cancer Research Products
More Tools
All Microbial Genomics Research
With the debut of the COVIDSeq Assay, smaller labs are participating in surveillance
All Microbial Genomics Products
All Informatics Products
More News
Identifying variants could help select highly productive breeds that adapt to rapidly changing climates
All Agrigenomics Products
The most comprehensive genotyping microarray on the market for pharmacogenomic research now at 25% off, restrictions apply
All Complex Disease Research Products
TBD
Comprehensive genomic profiling is driving innovation across the 51-hospital system
All Reproductive Health
The collaboration will introduce VeriSeq NIPT Solution v2 in Southeast Asia
All Reproductive Health Products
Illumina supports the release of a landmark consensus on whole-genome sequencing in the diagnosis of genetic diseases in newborns
All Genetic Health Products
Corporate
Francis deSouza's first one-on-one interview as President and CEO of Illumina.
